The study that led the U.N.’s World Health Organization (W.H.O.) to halt clinical trials of the drug hydroxychloroquine (HCQ) as a treatment for the infection caused by the Chinese coronavirus has been called into question..
..In a column at the Association of American Physicians and Surgeons, Dr. Elizabeth Lee Vliet, wrote of the significance of HCQ, coupled with zinc, to be used at early onset of COVID-19 symptoms.
“More studies have replicated these findings,” she explained. “HCQ given within the first week of symptoms, especially with zinc, can prevent the virus from entering your body’s cells and taking over, much like people use locks and alarms to stop burglaries”..
WHO benefits from the halt of clinical trials of HCQ and the restrictions on its use?
- Forums
- Science & Medicine
- Hydroxychloroquine and Azithromycin Yes
The study that led the U.N.’s World Health Organization (W.H.O.)...
-
- There are more pages in this discussion • 54 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online